Mary EllenMartinMD

Hematologic Oncology

Physician

Dr. Martin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Civic Center Blvd, South Pavilion, 12-152
Philadelphia, PA 19104
Phone+1 215-349-8940

Fax+1 215-615-5887

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1999 - 2002
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1996 - 1999
State University of New York Downstate Medical Center College of MedicineClass of 1996

PubMed

Evolving racial/ethnic disparities in AML survival in the novel therapy era.
Xin Wang, Phyllis A Gimotty, Andrew H Matthews, Ronac Mamtani, Selina M Luger
Blood Advances. 2025-02-11
Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen.
Margaret Rowe, Daria Babushok, Martin Carroll, Alison Carulli, Noelle Frey
European Journal of Haematology. 2024-12-26
4 citations
Cytokine-mediated CAR T therapy resistance in AML.
Anand S Bhagwat, Leonel Torres, Olga Shestova, Maksim Shestov, Patrick W Mellors
Nature Medicine. 2024-12-01

Abstracts/Posters

Fried Frailty Phenotype Predicts Mortality for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Mary Ellen Martin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Outcomes of Allogeneic Stem Cell Transplantation for AML and MDS Based on Pre-Transplant MRD Status By Next-Generation Sequencing
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018